Novartis will soon publish its balance sheet for the past quarter – the analyst estimates.
Novartis will present the figures for the most recent quarter, which ended on March 31, 2026, at the financial conference on April 28, 2026.
On average, 9 analysts estimate that Novartis generated profit of $2.10 per share in the most recent quarter. In the same quarter last year it was CHF 1.65 per share.
Sales estimates from 9 analysts for the last quarter are at USD 13.46 billion, which compares to sales of CHF 11.90 billion in the same quarter last year.
For the current fiscal year, 21 analysts expect an average profit per share of USD 8.76, whereas CHF 5.99 was reported in the previous year. On the sales side, 21 analysts estimate on average that a total of USD 56.98 billion will be generated in the current fiscal year, compared to CHF 45.29 billion a year earlier.
Editorial team finanzen.net
Selected leveraged products on Novartis
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Novartis
The leverage must be between 2 and 20
Advertising
